nepafenac has been researched along with Central Retinal Edema, Cystoid in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (11.43) | 29.6817 |
| 2010's | 26 (74.29) | 24.3611 |
| 2020's | 5 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hepokur, M; Yılmaz Çebi, A | 1 |
| Chen, X; Li, SS; Wang, HH; Wang, YL; Zhang, DW | 1 |
| Ilveskoski, L; Taipale, C; Tuuminen, R | 1 |
| Bae, SS; Ching, G; Covello, AT; Holland, S; Iovieno, A; McCarthy, M; Ritenour, R; Yeung, SN | 1 |
| Betancor Caro, N; Mesa Lugo, FI; Quijada Fumero, E; Serrano García, M; Tapia Quijada, HE | 1 |
| Akpolat, Ç; Çekiç, O; Evliyaoğlu, F; Kurt, MM; Nuri Elçioğlu, M | 1 |
| Campa, C; Perri, P; Salsini, G | 1 |
| Alves, MR; Hida, WT; Morato, CS; Neves, NT; Tzelikis, PF | 1 |
| Pan, U; Sengupta, S; Sindal, M; Vasavada, D | 1 |
| Georgakopoulos, CD; Makri, OE; Pallikari, A; Plotas, P; Tsapardoni, F; Tsekouras, IK | 1 |
| Abu Eleinen, KG; Darwish, EA; El Gharbawy, SA; Osman, MH | 1 |
| Hieda, O; Inatomi, T; Kayukawa, K; Kinoshita, S; Kitazawa, K; Mori, K; Sotozono, C; Wakimasu, K | 1 |
| Holmström, E; Laine, I; Lindholm, JM; Taipale, C; Tuuminen, R; Ylinen, P | 1 |
| Baćko, M; Chaniecki, P; Nowak, M; Renke, P; Rucka, A; Ścisłowicz, A | 1 |
| Elies, D; Gris, O; Güell, JL; Ponce de Los Ríos, CD | 1 |
| Artzen, D; Laurell, CG; Montan, P; Stenevi, U; Zaczek, A | 1 |
| Alves, MR; Hida, WT; Motta, AF; Nakano, CT; Nakano, EM; Tzelikis, PF; Vieira, M | 1 |
| Almukhtar, TH; Baker, CW; Bressler, NM; Elman, MJ; Friedman, SM; Glassman, AR; Jampol, LM; Maker, MP; Melia, M | 1 |
| Kerci, SG; Küsbeci, T; Örsel, T; Sağban, L; Uzunel, UD; Yüksel, B | 1 |
| Mukesh, B; Pollack, A; Reiser, H; Sager, D; Singh, RP; Staurenghi, G | 1 |
| Horiguchi, M; Mizuguchi, T; Seno, Y; Suzuki, K; Tanikawa, A | 1 |
| Duch, S; Franco, IJ; Hernández, SJG; Milla, E; Rios, J; Stirbu, O | 1 |
| Pavesio, C; Petrushkin, H; Rogers, D | 1 |
| Harris, A; Kassm, T; Kew, C; Lane, L; Levine, J; McCafferty, S; Raven, M | 1 |
| Adewale, A; Alpern, L; Cervantes-Coste Cervantes, G; Jaffe, GJ; Jong, K; Lehmann, R; Martel, J; Modi, S; Pollack, A; Singh, RP; Staurenghi, G; Svoboda, L; Tsorbatzoglou, A | 1 |
| Cohen, KL; Mathys, KC | 1 |
| Bahrani, H; Fox, JE; Warren, KA | 1 |
| Miyake, G; Miyake, K; Numaga, J; Ota, I | 1 |
| Garg, S; Khanduja, S; Kumar, S; Naithani, P; Puranik, S; Vashisht, N | 1 |
| Cojocaru, I; Pop, A; Stefan, C | 1 |
| Almeida, DR; Bakar, SN; El-Defrawy, SR; Khan, Z; Rahim, K; Urton, T; Xing, L | 1 |
| Kim, T; Lindstrom, R | 1 |
| Braunstein, A; Braunstein, RE; Shih, C; Wolf, EJ | 1 |
| Callanan, D; Gainey, S; Hariprasad, SM; He, YG; Warren, K | 1 |
| Di Pascuale, MA; Mootha, VV; Whitson, JT | 1 |
3 review(s) available for nepafenac and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Cataract; Cataract Extraction; Dexamethasone; Diclofenac; Fluorometholone; Humans; Macular Edema; Treatment Outcome | 2023 |
[Progresses in antiinflamatory treatment in cataract surgery].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Drug Therapy, Combination; Eye Diseases; Glucocorticoids; Humans; Inflammation; Macular Edema; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Phenylacetates; Postoperative Care; Treatment Outcome | 2011 |
Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Clinical Trials as Topic; Humans; Macular Edema; Phenylacetates; Retinitis; United States | 2006 |
17 trial(s) available for nepafenac and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Anti-inflammatory Medication of Cataract Surgery in Pseudoexfoliation Syndrome - NSAID Is Needed.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Drug Therapy, Combination; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Glucocorticoids; Humans; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Patient Satisfaction; Phacoemulsification; Phenylacetates; Prednisolone; Prospective Studies; Quality of Life; Surveys and Questionnaires; Visual Acuity | 2020 |
Retinal Vascular Caliber Changes After Topical Nepafenac Treatment for Diabetic Macular Edema.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Phenylacetates; Prospective Studies; Retinal Vessels; Tomography, Optical Coherence; Visual Acuity | 2018 |
Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cataract Extraction; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Macula Lutea; Macular Edema; Male; Ophthalmic Solutions; Phenylacetates; Prospective Studies; Pseudophakia; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |
Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Phacoemulsification; Phenylacetates; Postoperative Complications; Prospective Studies; Slit Lamp; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |
Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract; Drug Combinations; Female; Glucocorticoids; Humans; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Postoperative Complications; Prednisolone; Prospective Studies; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2019 |
Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Postoperative Complications; Prospective Studies; Uveitis, Anterior; Visual Acuity | 2014 |
Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Female; Humans; Ketorolac; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Postoperative Complications; Prospective Studies; Refraction, Ocular; Retina; Tomography, Optical Coherence; Visual Acuity | 2015 |
Topical nepafenec in eyes with noncentral diabetic macular edema.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Double-Blind Method; Female; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Retina; Tomography, Optical Coherence; Visual Acuity | 2015 |
Comparison of Subtenon Triamcinolone Acetonide Injection with Topical Nepafenac for the Treatment of Pseudophakic Cystoid Macular Edema.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Phenylacetates; Prospective Studies; Pseudophakia; Retina; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2017 |
Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Diabetic Retinopathy; Double-Blind Method; Female; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Postoperative Complications; Treatment Outcome | 2017 |
Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Phacoemulsification; Phenylacetates; Prospective Studies; Pseudophakia; Risk Factors; Tomography, Optical Coherence; Visual Acuity | 2017 |
Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract; Diabetic Retinopathy; Double-Blind Method; Female; Humans; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Postoperative Care; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2017 |
Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Female; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Phacoemulsification; Phenylacetates; Postoperative Care; Preoperative Care; Prospective Studies; Tomography, Optical Coherence; Visual Acuity | 2010 |
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzeneacetamides; Benzophenones; Bevacizumab; Bromobenzenes; Diclofenac; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Ketorolac; Macular Edema; Male; Middle Aged; Phenylacetates; Pseudophakia; Retina; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Blood-Aqueous Barrier; Double-Blind Method; Female; Fluorescein Angiography; Fluorometholone; Glucocorticoids; Humans; Lens Implantation, Intraocular; Macular Edema; Male; Microsurgery; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Photometry; Postoperative Complications; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2011 |
Role of topical nepafenac in prevention and treatment of macular edema after vitreoretinal surgery.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Eye Pain; Female; Humans; Macular Edema; Male; Pain, Postoperative; Phenylacetates; Visual Acuity; Vitreoretinal Surgery | 2012 |
Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Female; Health Status; Humans; Ketorolac; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Postoperative Complications; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tomography, Optical Coherence; Treatment Outcome | 2012 |
15 other study(ies) available for nepafenac and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
OCT imaging of macular cysts and treatment response with nepafenac in mucopolysaccharidosis type 1.
Topics: Female; Fluorescein Angiography; Humans; Iduronidase; Macular Edema; Mucopolysaccharidosis I; Retina; Retinitis Pigmentosa; Retrospective Studies; Tomography, Optical Coherence | 2023 |
Incidence and Outcomes of Cystoid Macular Edema after Descemet Membrane Endothelial Keratoplasty (DMEK) and DMEK Combined with Cataract Surgery.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract; Cataract Extraction; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Drug Therapy, Combination; Female; Humans; Incidence; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Prednisolone; Retrospective Studies; Risk Factors; Slit Lamp Microscopy; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2021 |
Nepafenac for cystoid macular oedema secondary to paclitaxel.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Benzeneacetamides; Humans; Macular Edema; Male; Middle Aged; Paclitaxel; Phenylacetates | 2021 |
Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Phenylacetates; Prednisolone; Pseudophakia; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |
Cystoid Macular Edema Due to Accidental Latanoprost Overdose After Uncomplicated Phacoemulsification.
Topics: Acetazolamide; Aged; Antihypertensive Agents; Benzeneacetamides; Drug Overdose; Humans; Latanoprost; Macular Edema; Male; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Visual Acuity | 2018 |
Topical non-steroidal anti-inflammatory drugs for the treatment of cystoid macular edema post Descemet's stripping automated endothelial keratoplasty.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Female; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Postoperative Complications; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |
Postoperative management in cataract surgery: nepafenac and preservative-free diclofenac compared.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Diclofenac; Double-Blind Method; Drug Tolerance; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Postoperative Care; Preservatives, Pharmaceutical; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome | 2018 |
[Visual disorder after visual contact with a geodetic laser].
Topics: Accidents, Occupational; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Humans; Lasers; Light; Macular Edema; Male; Phenylacetates; Visual Acuity; Young Adult | 2018 |
Progressive corneal clearance after a DMEK graft partially folded over on itself in a non-fuchs pseudophakic eye.
Topics: Acetazolamide; Aged; Benzeneacetamides; Cataract Extraction; Cornea; Corneal Edema; Descemet Stripping Endothelial Keratoplasty; Endothelium, Corneal; Fuchs' Endothelial Dystrophy; Humans; Lens Implantation, Intraocular; Macular Edema; Male; Phenylacetates; Postoperative Complications; Pseudophakia; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2014 |
Cystoid macular edema associated with iridocorneal endothelial syndrome: a case report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Female; Humans; Iridocorneal Endothelial Syndrome; Macular Edema; Middle Aged; Phenylacetates; Treatment Outcome | 2016 |
Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzeneacetamides; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Fovea Centralis; Glaucoma; Humans; Macular Edema; Male; Middle Aged; Phacoemulsification; Phenylacetates; Pilot Projects; Postoperative Complications; Retrospective Studies; Tomography, Optical Coherence | 2017 |
The Use of Topical Non-steroidal Anti-inflammatory Drugs for Uveitic Cystoid Macular Edema.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Female; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Phenylacetates; Tomography, Optical Coherence; Uveitis; Visual Acuity | 2018 |
Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Incidence; Macular Edema; Male; Middle Aged; Phacoemulsification; Phenylacetates; Postoperative Complications; Prednisolone; Pseudophakia; Retrospective Studies | 2007 |
Cystoid and diabetic macular edema treated with nepafenac 0.1%.
Topics: Aged; Benzeneacetamides; Cataract Extraction; Diabetic Retinopathy; Female; Humans; Lenses, Intraocular; Macular Edema; Male; Phenylacetates; Steroids; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2007 |
Corneal melting after use of nepafenac in a patient with chronic cystoid macular edema after cataract surgery.
Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Corneal Diseases; Female; Humans; Macular Edema; Phenylacetates; Visual Acuity | 2008 |